VEITHsymposium™

Program (November 2021)

The program features over 1,300 rapid-fire presentations offered in more than 100 sessions throughout the five-day event. Click on the day below to review the sessions, then click on the session number to see a listing of presentations and speakers within a session.

View/Search/Print Complete 2021 Program Brochure in PDF
View/Print Entire November 2021 Program

Program Outline at a Glance

TUESDAY PROGRAMS
Program A:	(Sessions 1-10) 6:45 A.M. – 6:15 P.M. (9.75 CME CREDIT HOURS) (Session 1-8) 6:45 A.M. - 3:21 P.M. Progress In Transcatheter Heart Valves And Thoracic And Abdominal Aortic Disease (Sessions 9 and 10) 3:22 PM – 6:15 PM) Management of Pulmonary Embolism
Location:	LECTURE HALL 1 - BONNET CREEK BALLROOM

Program B:	(Sessions 11-22) 6:50 A.M. – 6:10 P.M. (10 CME CREDIT HOURS) (Sessions 11-20) 6:50 A.M. - 5:00 P.M. Progress In Vascular Robotics, Guidance Systems, Simulation And Laparoscopy; New Developments In Carotid Disease And Acute Stroke Treatment; Abdominal Aortic Branch Treatment; Hot New Topics In Lower Extremity Occlusive Disease Treatment; New Technology, New Concepts And Artificial Intelligence (AI); Vascular Surgery Recognition, Identity And Independence; Updates On Open And Hybrid Vascular Surgery And Treatment Of Aortic Coarctation (Sessions 21-22) 5:00 P.M. - 6:10 P.M. Updates On Vascular Malformations And Their Treatment
Location:	LECTURE HALL 2 - FLORIDIAN BALLROOM

WEDNESDAY PROGRAMS
Program C:	(Sessions 23-32) 6:40 A.M. – 5:31 P.M. (9.5 CME CREDIT HOURS) (Sessions 23-30) 6:40 A.M. – 3:56 P.M. Progress In Lower Extremity Occlusive Disease And Its Treatment (Sessions 31 and 32) 3:56 P.M. - 5:40 PM New Developments In Medical Treatments And New Drugs; Progress In Antiatherogenic, Antihypertensive And Cardiac Treatments: Cardiac Effects Of COVID - 19
Location:	LECTURE HALL 1 - BONNET CREEK BALLROOM

Program D:	(Sessions 33-42) 7:00 A.M. – 6:10 P.M. (10 CME CREDIT HOURS) Management Of Endoleaks; More Topics Related To Thoracic And Abdomial Aortic Diseases And Their Treatment; Treatment Of Complex AAAs; Treatment Of Iliac Aneurysms; Iliac Branched Devices And Miscellaneous Topics Related To Reimbursement, Outpatient Labs, the FDA And The SVS VQI
Location:	LECTURE HALL 2 - FLORIDIAN BALLROOM

THURSDAY PROGRAMS
Program E:	(Sessions 43-50) 7:00 A.M. – 5:25 P.M. (8.5 CME CREDIT HOURS) Exciting New Or Rediscovered Techniques, Concepts Or Devices; Progress In F/B/EVAR And Parallel Grafts For Complex AAAs; Tribute To Our Military; Progress In The Treatment Of Ruptured AAA; More About New Devices, Techniques Or Concepts; Progress In Radiation Safety
Location:	LECTURE HALL 1 - BONNET CREEK BALLROOM

Program F:	(Sessions 51-59) 7:00 A.M. – 5:30 P.M. (8.75 CME CREDIT HOURS) New Or Improved Devices For: Standard EVAR, EVAS And More Complex AAAs; Repairs Of TAAAs, The Ascending Aorta, The Aortic Arch, And The Descending Aorta (TEVAR); New Devices For Treating Lower Extremity Lesions By Endo Or Open Techniques; Update On Endoanchors And Fixation Devices And New Or Improved Devices For Endovascularly Removing Clot And Occluding Blood Vessels
Location:	LECTURE HALL 2 - FLORIDIAN BALLROOM

Program G:	(Sessions 60-69) 8:00 A.M. – 5:55 P.M. (8.5 CME CREDIT HOURS) Superficial Venous Disease Course Leaders: Jose I. Almeida, MD, Lowell S. Kabnick,MD , Thomas W. Wakefield, MD and Steve Elias, MD
Location:	LECTURE HALL 3 - WALDORF ASTORIA GRAND BALLROOM A

Program H:	(Sessions 70-72) 7:45 A.M. – 12:10 P.M. (3.75 CME CREDIT HOURS) Cerebrovascular Disease And Its Treatment Course Leader: Allan L. Brook, MD
Location:	LECTURE HALL 4 - FLORIDIAN BALLROOM, SALON H

FRIDAY PROGRAMS
Program I:	(Sessions 73-80) 7:00 A.M. – 4:50 P.M. (8.25 CME CREDIT HOURS) Progress In The Prevention And Treatment Of Spinal Cord Ischemia (SCI) With TAAAs And Complex Aortic Aneurysm Repairs; New Developments In Carotid Artery Disease And Its Treatment: Mesh Covered Stents And TCAR, Cognitive Changes, Timing Of Treatment, Medical Treatment, Update On Carotid Trials, Treatment Of Asymptomatic Carotid Stenosis (ACS), Carotid Clot And More Carotid Topics; Other New Endovascular Treatment Concepts, Techniques; Update On Percutaneous Access Closure Devices And Wound Care
Location:	LECTURE HALL 1 - BONNET CREEK BALLROOM

Program J:	(Sessions 81-88) 7:20 A.M. – 5:30 P.M. (8.25 CME CREDIT HOURS) New Developments In The Treatment Of Popliteal Disease: Aneurysms, Entrapment And Occlusive Lesions; Advances In Treating Arterial And Graft Infections; Advances In Vascular Imaging And Guidance; Recorded Live Cases: Complex Endovascular Cases From The Mayo Clinic; New Developments In Thoracic Outlet Syndrome Management; Advances In Medical, Drug, Anticoagulant And Rare Vascular Disease Treatment; And Advances In The Treatment Of Vascular Trauma
Location:	LECTURE HALL 2 - FLORIDIAN BALLROOM

Program K:	(Sessions 89-97) 7:30 A.M. – 4:45 P.M. (6.5 CME CREDIT HOURS) Deep Venous Disease
Location:	LECTURE HALL 3 - WALDORF ASTORIA GRAND BALLROOM A

SATURDAY PROGRAMS
Program L:	(Sessions 98-102) 7:00 A.M. – 1:05 P.M. (6 CME CREDIT HOURS) Topics Too Important To Miss In The Treatment Of Lower Extremity, Aortic Or Carotid Disease, COVID-19 Updates
Location:	LECTURE HALL 1 - BONNET CREEK BALLROOM

Program M:	(Sessions 103-106) 8:00 A.M. – 3:25 P.M. (6 CME CREDIT HOURS) Improving Outcomes In Hemodialysis AccesS
Location:	LECTURE HALL 2 - FLORIDIAN CREEK BALLROOM

Tuesday, November 16, 2021 - Program Details

Open All Tuesday Sessions

COMBINED PROGRAM FOR VASCULAR SURGERY, INTERVENTIONAL RADIOLOGY, CARDIOLOGY AND CARDIOTHORACIC SURGERY

6:00 AM - General Registration - Hilton Orlando Bonnet Creek, North Foyer
6:00 AM - Faculty Registration - Hilton Orlando Bonnet Creek Ballroom (Salon I)
6:15 AM - Continental Breakfast - Hilton Orlando Bonnet Creek
North and West Foyers

PROGRAMS A AND B ARE CONCURRENT TUESDAY PROGRAMS
PROGRAM A (SESSIONS 1-8: 6:45 A.M. - 3:21 P.M.): PROGRESS IN TRANSCATHETER HEART VALVES REPLACEMENT AND THORACIC AND ABDOMINAL AORTIC DISEASE; (SESSIONS 9 AND 10: 3:22 P.M. - 6:15 P.M.): MANAGEMENT OF PULMONARY EMBOLISM
SESSION 1:	PROGRESS IN TRANSCATHETER VALVE REPLACEMENT AND TREATMENT OF ASCENDING AORTIC DISEASE
SESSION 2:	PROGRESS IN THE TREATMENT OF AORTIC ARCH LESIONS AND AORTIC DISSECTIONS
SESSION 3:	PROGRESS IN THE ENDOVASCULAR TREATMENT OF AORTIC DISSECTIONS: REPORTING STANDARDS, CLASSIFICATION SYSTEMS, STABILISE, AND MORE
SESSION 4:	MORE NEW DEVELOPMENTS IN THE TREATMENT OF TBADs, THORACIC AORTIC DISEASE AND THORACOABDOMINAL ANEURYSMS (TAAAs)
SESSION 5:	NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) ETIOLOGY AND TREATMENT, EVAR AND EVAS (ENDOVASCULAR ANEURYSM SEALING)
SESSION 6:	MORE ABOUT AAAs, EVAR AND THE PUBLISHED UK NICE AAA GUIDELINES AND THEIR IMPACT ON AAA TREATMENT IN THE UK AND ELSEWHERE
SESSION 7:	MORE NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC DISSECTIONS AND THORACIC PATHOLOGY; STROKE PREVENTION WITH TEVAR
SESSION 8:	MORE NEW DEVELOPMENTS REGARDING TBADs AND TEVAR: NATURAL HISTORY; NEED FOR AND TIMING OF TEVAR FOR ACUTE UNCOMPLICATED TBADs
PROGRAM A CONTINUED (SESSIONS 9-10 - 3:22 P.M. - 6:15 P.M.): MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE TEAM APPROACH
SESSION 9:	MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 1
SESSION 10:	MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 2
PROGRAM B (SESSIONS 11-20: 6:50 A.M. - 5:00 P.M.): PROGRESS IN VASCULAR ROBOTICS, GUIDANCE SYSTEMS, SIMULATION AND LAPAROSCOPY; NEW DEVELOPMENTS IN CAROTID DISEASE AND ACUTE STROKE TREATMENT; ABDOMINAL AORTIC BRANCH TREATMENT; HOT NEW TOPICS IN LOWER EXTREMITY OCCLUSIVE DISEASE TREATMENT; NEW TECHNOLOGY, NEW CONCEPTS AND ARTIFICIAL INTELLIGENCE (AI); VASCULAR SURGERY RECOGNITION, IDENTITY AND INDEPENDENCE; UPDATES ON OPEN AND HYBRID VASCULAR SURGERY AND TREATMENT OF AORTIC COARCTATION; (SESSIONS 21 AND 22: 5:00 P.M. - 6:10 P.M.): UPDATES ON VASCULAR MALFORMATIONS AND THEIR TREATMENT
SESSION 11:	PROGRESS IN VASCULAR ROBOTICS, GUIDANCE SYSTEMS, LAPAROSCOPY AND SIMULATION
SESSION 12:	NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT; DIFFERING VIEWS ON TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND CAROTID SCREENING
SESSION 13:	MORE ABOUT CAROTID AND VERTEBRAL DISEASE: UPDATE ON INVASIVE TREATMENT FOR ACUTE STROKES
SESSION 14:	PROGRESS IN THE TREATMENT OF AORTIC AND AORTO-ILIAC OCCLUSIVE DISEASE
SESSION 15:	HOT NEW SHORT SUMMARY TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE
SESSION 16:	MORE HOT NEW SHORT SUMMARY TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND CHRONIC LIMB THREATENING ISCHEMIA (CLTI) (4 3/4-MINUTE TALKS)
SESSION 17:	NEW CONCEPTS, MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE (AI)
SESSION 18:	VASCULAR SURGERY’S NUMBERS, IDENTITY, RECOGNITION, INDEPENDENT SPECIALTY STATUS; HOW TO INCREASE OUR NUMBERS TO MEET FUTURE NEEDS FOR OUR SERVICES
SESSION 19:	PROGRESS IN THE TREATMENT OF VISCERAL AND RENAL ARTERY DISEASE
SESSION 20:	UPDATE ON OPEN VASCULAR SURGICAL AND HYBRID PROCEDURES; PROGRESS IN THE TREATMENT OF AORTIC COARCTATIONS
PROGRAM B CONTINUED (SESSIONS 21 - 22 - 5:00 P.M. - 6:06 P.M.): CURRENT STRATEGIES IN THE DIAGNOSIS AND CURATIVE TREATMENT OF VASCULAR MALFORMATIONS
SESSION 21:	ETHANOL ENDOVASCULAR CURATIVE TREATMENT OF VASCULAR MALFORMATIONS – PART 1
SESSION 22:	ETHANOL ENDOVASCULAR CURATIVE TREATMENT OF VASCULAR MALFORMATIONS – PART 2

Wednesday, November 17, 2021 - Program Details

Open All Wednesday Sessions

PROGRAMS C AND D ARE CONCURRENT WEDNESDAY PROGRAMS
PROGRAM C (SESSIONS 23-32 - 6:40 A.M. - 5:31 P.M.): PROGRESS IN LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENT; NEW DEVELOPMENTS IN MEDICAL TREATMENTS AND NEW DRUGS; PROGRESS IN ANTI ATHEROGENIC, ANTIHYPERTENSIVE AND CARDIAC TREATMENTS: CARDIAC EFFECTS OF COVID-19
SESSION 23:	GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI
SESSION 24:	NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE)
SESSION 25:	LOWER EXTREMITY TOPICS RELATED TO THE DRUG COATED DEVICES CAUSING INCREASED MORTALITY CONTROVERSY: DO PACLITAXEL COATED DEVICES CAUSE INCREASED MORTALITY (5 AND 4 ¾-MINUTE SHORT SUMMARY [SS] TALKS)
SESSION 26:	NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK LESION TREATMENTS WITH DCBs AND DESs (5-MINUTE TALKS)
SESSION 27:	PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: HOW TO SAVE THE “NO OPTION FOR TREATMENT” LIMB OR THE “DESERT FOOT” WITH NO PATENT TARGET ARTERIES
SESSION 28:	NEW DEVELOPMENTS IN STENTS; PROSTHETIC GRAFTS; ENDOVASCULAR BYPASSES; STENT GRAFTS AND TREATMENT OF IN STENT RESTENOSIS (ISR)
SESSION 29:	LOWER EXTREMITY TRIALS; GUIDELINES; FOOT PERFUSION EVALUATION METHODS AND VALUE OF ANGIOSOMES
SESSION 30:	NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION AND ACUTE LIMB ISCHEMIA
PROGRAM C CONTINUED (SESSIONS 31 AND 32 - 3:56 P.M. - 5:40 P.M.): NEW DEVELOPMENTS IN MEDICAL TREATMENTS AND NEW DRUGS; PROGRESS IN ANTIATHEROGENIC, ANTIHYPERTENSIVE AND CARDIAC TREATMENTS: CARDIAC EFFECTS OF COVID-19
SESSION 31:	ADVANCES IN MEDICAL TREATMENTS, NEW ANTIATHEROGENIC DRUGS, VALUE OF RIVAROXABAN AND PREVENTING MIs IN VASCULAR SURGERY PATIENTS
SESSION 32:	CATHETER BASED TREATMENTS OF RESISTANT HYPERTENSION; MANAGEMENT OF CARDIAC PROBLEMS, SMOKING AND TRANSFUSION IN VASCULAR SURGERY PATIENTS; MORTALITY RISK IN STROKE PATIENTS; VASCULAR AND CARDIAC COMPLICATIONS OF COVID-19
PROGRAM D (SESSIONS 33-42 - 7:00 A.M. - 6:10 P.M.): MANAGEMENT OF ENDOLEAKS; MORE TOPICS RELATED TO THORACIC AND ABDOMINAL AORTIC DISEASE AND THEIR TREATMENT; TREATMENT OF COMPLEX AAAs; TREATMENT OF ILIAC ANEURYSMS; ILIAC BRANCHED DEVICES AND MISCELLANEOUS TOPICS RELATED TO REIMBURSEMENT, OUTPATIENT LABS, THE FDA AND THE SVS VQI
SESSION 33:	PROGRESS IN MANAGING ENDOLEAKS: UNDERSTANDING THEIR CONSEQUENCES AND PREDICTING, PREVENTING AND TREATING THEM
SESSION 34:	PREVENTION OF TYPE 2 ENDOLEAKS AFTER EVAR
SESSION 35:	MORE TOPICS RELATED TO THE THORACIC AORTA, AORTIC DISSECTIONS, INTRAMURAL HEMATOMAS (IMHs) AND THEIR TREATMENT
SESSION 36:	MORE ADVANCES RELATED TO LESIONS INVOLVING THE ASCENDING AORTA AND THE AORTIC ARCH; AORTIC DISSECTIONS AND THEIR TREATMENT
SESSION 37:	OPEN AND ENDO TREATMENT OF COMPLEX AAAs (JUXTA, PARA- AND SUPRA-RENAL) AND TAAAs; NEW DEVICES FOR THEIR TREATMENT
SESSION 38:	PROGRESS IN TREATING ILIAC ANEURYSMS; ILIAC BRANCHED DEVICES (IBDs); UPDATE ON MULTILAYER FLOW MODULATING (MLFM) AND OTHER BARE STENTS FOR TREATING ANEURYSMS AND DISSECTIONS
SESSION 39:	MORE NEW DEVELOPMENTS IN AAA TREATMENT AND STANDARD EVAR: A NEW DEVICE TO SLOW AAA GROWTH; AAA NECK DILATATION AFTER EVAR; VALUE OF LOW PROFILE AAA ENDOGRAFTS; LINK TO CANCER; IMPROVED ULTRASOUND SURVEILLANCE AND ALL AAAs ARE NOT TIME BOMBS WAITING TO EXPLODE
SESSION 40:	MORE NEW DEVELOPMENTS IN AAAs: HOW DO THEIR NECK AND SAC SIZE AND THROMBUS LOAD EFFECT PROGNOSIS AFTER EVAR AND EVAS; OTHER RELATED AAA TOPICS
SESSION 41:	HOT AORTIC TOPICS (4 ¾ AND 5--MINUTE FAST PACED TALKS)
SESSION 42:	MORE SHORT HOT NEW TOPICS RELATED TO AORTIC DISEASE AND ITS TREATMENT AND MISCELLANEOUS TOPICS

Thursday, November 18, 2021 - Program Details

Open All Thursday Sessions

PROGRAMS E, F AND G ARE CONCURRENT THURSDAY PROGRAMS
PROGRAM E (SESSIONS 43-50; 7:00 A.M. - 5:25 P.M.): EXCITING NEW OR REDISCOVERED TECHNIQUES, CONCEPTS OR DEVICES; PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs; TRIBUTE TO OUR MILITARY; PROGRESS IN THE TREATMENT OF RUPTURED AAA; MORE ABOUT NEW DEVICES, TECHNIQUES OR CONCEPTS; PROGRESS IN RADIATION SAFETY
SESSION 43:	EXCITING NEW OR REDISCOVERED TECHNIQUES, DEVICES OR CONCEPTS
SESSION 44:	PROGRESS IN FENESTRATED AND BRANCHED EVAR (F/B/EVAR) AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
SESSION 45:	MORE PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
SESSION 46:	A TRIBUTE TO OUR MILITARY AND MILITARY PHYSICIANS: SOME MILITARY HISTORY; TREATMENT OF MILITARY AND CIVILIAN VASCULAR INJURIES AND CONTROL OF HEMORRHAGE; INNOVATIVE TECHNOLOGIES SUPPORTED BY THE DEFENSE DEPARTMENT
SESSION 47:	PROGRESS IN THE TREATMENT OF RUPTURED INFRARENAL AAAs, COMPLEX AAAs, TAAAs AND RELATED TOPICS
SESSION 48:	MORE NEW DEVELOPMENTS IN RUPTURED AAAs AND TAAAs; WHAT IS AND SHOULD BE HAPPENING WITH AAA SCREENING
SESSION 49:	EXCITING NEW OR UPDATED CONCEPTS, TECHNIQUES AND TREATMENTS
SESSION 50:	PROGRESS IN RADIATION SAFETY AND MORE NEW CONCEPTS, DEVICES AND TECHNIQUES
PROGRAM F (SESSIONS 51-59 - 7:00 A.M. - 5:30 P.M.); NEW OR IMPROVED DEVICES FOR: STANDARD EVAR, EVAS AND MORE COMPLEX AAAs; REPAIRS OF TAAAs, THE ASCENDING AORTA, THE AORTIC ARCH, AND THE DESCENDING AORTA (TEVAR); NEW DEVICES FOR TREATING LOWER EXTREMITY LESIONS BY ENDO OR OPEN TECHNIQUES; UPDATE ON ENDOANCHORS AND FIXATION DEVICES AND NEW OR IMPROVED DEVICES FOR ENDOVASCULARLY REMOVING CLOT AND OCCLUDING BLOOD VESSELS
SESSION 51:	NEW OR IMPROVED DEVICES FOR INFRARENAL AAA REPAIR WITH STANDARD EVAR (5-MINUTE TALKS)
SESSION 52:	NEW OR UPDATED DEVICES FOR STANDARD EVAR, EVAS (ENDOVASCULAR ANEURYSM SEALING) AND F/EVAR
SESSION 53:	NEW OR IMPROVED DEVICES FOR THE ASCENDING AORTA, THE AORTIC ARCH OR NEAR THE ARCH
SESSION 54:	NEW OR IMPROVED DEVICES FOR THORACIC AORTIC LESION REPAIRS (TEVAR) AND FOR THORACOABDOMINAL ANEURYSM (TAAA) REPAIRS (ALL TALKS ARE 4 ¾-MINUTES)
SESSION 55:	NEW OR UPDATED INFORMATION ON BALLOON EXPANDABLE COVERED STENTS, LOWER EXTREMITY PROSTHETIC GRAFTS, BIORESORBABLE GRAFTS, PERIGRAFT SEROMA AND VALUE OF A PROSTHETIC PERIGRAFT SIROLIMUS PATCH [SEE ALSO SESSION 28] ALL TALKS ARE 5 MINUTES)
SESSION 56:	NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, TACKS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
SESSION 57:	NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ANGIOPLASTY BALLOONS
SESSION 58:	NEW OR IMPROVED DEVICES AND TECHNIQUES TO PREVENT OR TREAT ENDOLEAKS OR DEVICE MIGRATION: ENDOANCHORS, ETC.
SESSION 59:	NEW OR IMPROVED ENDOVASCULAR DEVICES FOR CLOT REMOVAL OR EMBOLIZATION (SEE ALSO SESSION 30)
PROGRAM G (SESSIONS 60-69 - 8:00 A.M. - 5:50 P.M.): SUPERFICIAL VENOUS DISEASE
SESSION 60:	VENOUS CLINICAL EXAMINATION AND HEMODYNAMICS
SESSION 61:	VENOUS IMAGING AND BIOLOGY
SESSION 62:	SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES
SESSION 63:	THERMAL AND NON-THERMAL ABLATION – PART 1
SESSION 64:	THERMAL AND NON-THERMAL ABLATION – PART 2
SESSION 65:	SPIDER VEINS, TRUNCAL VEINS, TRIBUTARY VEINS, EXOTIC VEIN TREATMENT
SESSION 66:	VENOUS SOCIETAL AND GOVERNANCE
SESSION 67:	MORE SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES
SESSION 68:	VENOUS CLINICAL TRIALS; LYMPHATIC AND VEIN TREATMENT STRATEGIES
SESSION 69:	LIPEDEMA, LYMPHEDEMA, PHLEBOLYMPHEDEMA
PROGRAM H (SESSIONS 70-72 - 7:45 A.M. - 12:10 P.M.): CEREBROVASCULAR
SESSION 70:	STROKE 2021 INCLUDING COVID
SESSION 71:	CAROTIDS AND REVASCULARIZATION
SESSION 72:	INTRACRANIAL HEMORRHAGE

Friday, November 19, 2021 - Program Details

Open All Friday Sessions

PROGRAMS I, J AND K ARE CONCURRENT FRIDAY PROGRAMS
PROGRAM I (SESSIONS 73-80 - 7:00 A.M. - 4:50 P.M.): PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) WITH TAAAs AND COMPLEX AORTIC ANEURYSM REPAIRS; NEW DEVELOPMENTS IN CAROTID ARTERY DISEASE AND ITS TREATMENT: MESH COVERED STENTS AND TCAR, COGNITIVE CHANGES, TIMING OF TREATMENT, MEDICAL TREATMENT, UPDATE ON CAROTID TRIALS, TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS), CAROTID CLOT AND MORE CAROTID TOPICS; OTHER NEW ENDOVASCULAR TREATMENT CONCEPTS, TECHNIQUES; UPDATE ON PERCUTANEOUS ACCESS CLOSURE DEVICES AND WOUND CARE
SESSION 73:	PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) ASSOCIATED WITH THE TREATMENT OF THORACIC, THORACOABDOMINAL AND COMPLEX ABDOMINAL ANEURYSMS
SESSION 74:	NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS WITH MESH COVERED STENTS AND TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION (TCAR)
SESSION 75:	MORE CAROTID HOT TOPICS RELATED TO TCAR, MINI-INCISION CEA, SIGNIFICANCE OF DW MRI DEFECTS AND COGNITIVE FUNCTION
SESSION 76:	MORE CAROTID RELATED NEW DEVELOPMENT TOPICS RELATED TO TCAR, MESH COVERED STENTS, MINI-INCISION CEA, TIMING OF TREATMENT, MEDICAL TREATMENT AND DEALING WITH DISTAL (HIGH) CAROTID LESIONS
SESSION 77:	MORE HOT CAROTID TOPICS: UPDATES ON KEY CAROTID RCTs; NEW INFORMATION ON TREATMENT OF TANDEM LESIONS, CAROTID ANEURYSMS AND STROKES DURING INTERVENTION
SESSION 78:	MORE HOT CAROTID TOPICS: TREATMENT IN 2021 OF BIG CAROTID BODY TUMORS, OPTIMAL PLATELET AND PROTAMINE STRATEGIES; BENIGNANCY OF ACS
SESSION 79:	NEW OR UPDATED CONCEPTS FOR ENDOVASCULAR TREATMENTS
SESSION 80:	NEW DEVELOPMENTS IN PERCUTANEOUS ACCESS CLOSURE, ENDOVASCULAR SUTURING AND WOUND CARE
PROGRAM J (SESSIONS 81-88 - 7:20 A.M. - 5:30 P.M.)
NEW DEVELOPMENTS IN THE TREATMENT OF POPLITEAL DISEASE: ANEURYSMS, ENTRAPMENT AND OCCLUSIVE LESIONS; ADVANCES IN TREATING ARTERIAL AND GRAFT INFECTIONS; ADVANCES IN VASCULAR IMAGING AND GUIDANCE; RECORDED LIVE CASES: COMPLEX ENDOVASCULAR CASES FROM THE MAYO CLINIC; NEW DEVELOPMENTS IN THORACIC OUTLET SYNDROME MANAGEMENT; ADVANCES IN MEDICAL, DRUG, ANTICOAGULANT AND RARE VASCULAR DISEASE TREATMENT; AND ADVANCES IN THE TREATMENT OF VASCULAR TRAUMA
SESSION 81:	POPLITEAL DISEASE TOPICS RELATED TO NEW GUIDELINES, ANEURYSM TREATMENT (PRIMARY AND REDO), ENTRAPMENTS AND ATHERECTOMY FOR OCCLUSIVE LESIONS
SESSION 82:	NEW DEVELOPMENTS IN TREATING ARTERIAL (INCLUDING AORTIC) INFECTIONS
SESSION 83:	PROGRESS IN VASCULAR IMAGING AND GUIDANCE FOR ENDOVASCULAR TREATMENTS WITH LESS RADIATION EXPOSURE OR CONTRAST TOXICITY
SESSION 84:	CHALLENGING RECORDED LIVE CASES FROM THE MAYO CLINIC AND THE UNIVERSITY OF TEXAS, HOUSTON
SESSION 85:	ONE PRESENTATION FROM MÜNSTER, GERMANY ON LOWER EXTREMITY STENTS
SESSION 86:	NEW DEVELOPMENTS IN THE TREATMENT OF THORACIC OUTLET SYNDROMES (TOSs)
SESSION 87:	NEW DEVELOPMENTS IN MEDICAL AND DRUG TREATMENTS: BEST ANTIPLATELET REGIMENS; UPDATE ON RARE VASCULAR DISEASES
SESSION 88:	ADVANCES IN THE ENDO AND OPEN TREATMENT OF VASCULAR TRAUMA
PROGRAM K (SESSIONS 89-97 - 7:20 A.M. - 4:45 P.M.): DEEP VENOUS DISEASE
SESSION 89:	PELVIC VENOUS DISORDERS, FEMORO-ILIOCAVAL INTERVENTIONAL STRATEGIES TO REDUCE VENOUS HYPERTENSION
SESSION 90:	CHRONIC VENOUS OBSTRUCTION
SESSION 91:	FEMORO-ILIOCAVAL INTERVENTIONAL STRATEGIES TO REDUCE VENOUS HYPERTENSION
SESSION 92:	HYBRID TECHNIQUES, STENT PROBLEMS, POST-IMPLANTATION
SESSION 93:	STRATEGIES FOR CORRECTING SEVERE DEEP VENOUS REFLUX AND/OR OBSTRUCTION, WOUNDS, MEDICINES, AND NEW HORIZONS FOR VENOUS DISEASE MANAGEMENT
SESSION 94:	VENOUS STENT TRIALS AND CONCEPTS
SESSION 95:	MORE ILIOFEMORAL FLOW AND PELVIC ISSUES
SESSION 96:	STRATEGIES FOR THROMBOEMBOLIC EVENTS IN THE VENOUS SYSTEM
SESSION 97:	DEEP VEIN VALVE TECHNOLOGIES, CAVAL INTERRUPTION

Saturday, November 20, 2021 - Program Details

Open All Saturday Sessions

6:00 AM - General Registration - Hilton Orlando Bonnet Creek, North Foyer
6:00 AM - Faculty Registration - Hilton Orlando Bonnet Creek Ballroom (Salon I)
6:30 AM - Continental Breakfast - Hilton Orlando Bonnet Creek
North and West Foyers

PROGRAMS L AND M ARE CONCURRENT SATURDAY PROGRAMS
PROGRAM L (SESSIONS 98-102 - 7:00 A.M. - 1:05 P.M.): TOPICS TOO IMPORTANT TO MISS IN THE TREATMENT OF LOWER EXTREMITY, AORTIC OR CAROTID DISEASE, COVID-19 UPDATES
SESSION 98:	LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS (4 ¾-MINUTE TALKS)
SESSION 99:	MORE LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS (5-MINUTE TALKS)
SESSION 100:	NEW DEVELOPMENTS IN COVID-19 TREATMENTS AND THE EFFECTS OF COVID-19 ON THE VASCULAR SYSTEM (5-MINUTE TALKS)
SESSION 101:	AORTIC TOPICS TOO IMPORTANT TO MISS (5-MINUTE TALKS)
SESSION 102:	AORTIC AND CAROTID TOPICS TOO IMPORTANT TO MISS 5-MINUTE TALKS)
PROGRAM M (SESSIONS 103-106 - 8:00 A.M. - 3:25 P.M.): IMPROVING OUTCOMES IN HEMODIALYSIS ACCESS
SESSION 103:	IMPORTANT ISSUES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
SESSION 104:	MORE IMPORTANT ISSUES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
SESSION 105:	POLITICAL, ECONOMIC AND LEGAL ISSUES IN HEMODIALYSIS ACCESS (7- 10-MINUTE TALKS)
SESSION 106:	NEW TECHNOLOGIES AND OTHER IMPORTANT CLINICAL ISSUES IN AV ACCESS (7-MINUTE TALKS)

Friday, November 19, 2021 -
Vascular Fellows' Career Development Program

Vascular Fellows’ Career Development Program

Friday, November 19, 2021 -8:00 a.m. - 5:00 p.m.
Hilton Orlando Bonnet Creek, Orlando, Florida
Waldorf Astoria Grand Ballroom B | This is a Non-CME activity.

VEITHsymposium provides vascular surgeons and other vascular specialists with a unique and exciting format to learn the most current information about what is new and important in the treatment of vascular disease. The 5-day event features rapid-fire presentations from world renowned vascular specialists with emphasis on the latest advances, changing concepts in diagnosis and management, pressing controversies and new techniques. Complimentary Tuition is provided through an Educational Grant by W.L. Gore & Associates, Inc. for Finishing Vascular Surgery Fellows in the US and Canada. An Educational Grant from Medtronic provides travel and lodging for Finishing Vascular Surgery Fellows and Residents in the US.

WHO SHOULD ATTEND: